Presentation is loading. Please wait.

Presentation is loading. Please wait.

Enhanced Effect of Combining Human Cardiac Stem Cells and Bone Marrow Mesenchymal Stem Cells to Reduce Infarct Size and to Restore Cardiac Function After.

Published byChristina Flowers Modified over 7 years ago

Similar presentations

Presentation on theme: "Enhanced Effect of Combining Human Cardiac Stem Cells and Bone Marrow Mesenchymal Stem Cells to Reduce Infarct Size and to Restore Cardiac Function After."— Presentation transcript:

1 Enhanced Effect of Combining Human Cardiac Stem Cells and Bone Marrow Mesenchymal Stem Cells to Reduce Infarct Size and to Restore Cardiac Function After Myocardial InfarctionClinical Perspective by Adam R. Williams, Konstantinos E. Hatzistergos, Benjamin Addicott, Fred McCall, Decio Carvalho, Viky Suncion, Azorides R. Morales, Jose Da Silva, Mark A. Sussman, Alan W. Heldman, and Joshua M. Hare Circulation Volume 127(2):213-223 January 15, 2013 Copyright © American Heart Association, Inc. All rights reserved.

2 Infarct size reduction after human cardiac stem cell (hCSC) and bone marrow mesenchymal stem cell (hMSC) therapy. Adam R. Williams et al. Circulation. 2013;127:213-223 Copyright © American Heart Association, Inc. All rights reserved.

3 Restoration of left ventricular (LV) function and attenuation of remodeling with human cardiac stem cell (hCSC) and human mesenchymal stem cell (hMSC) therapy. Adam R. Williams et al. Circulation. 2013;127:213-223 Copyright © American Heart Association, Inc. All rights reserved.

4 Impact of human cardiac stem cell (hCSC) and human mesenchymal stem cell (hMSC) therapy on diastolic function. Adam R. Williams et al. Circulation. 2013;127:213-223 Copyright © American Heart Association, Inc. All rights reserved.

5 Preload, afterload, and contractility changes after human cardiac stem cells (hCSC) and human mesenchymal stem cell (hMSCs). Adam R. Williams et al. Circulation. 2013;127:213-223 Copyright © American Heart Association, Inc. All rights reserved.

6 Integrated measures of cardiac performance improve after human cardiac stem cell (hCSC) and human mesenchymal stem cell (hMSC) therapy. Adam R. Williams et al. Circulation. 2013;127:213-223 Copyright © American Heart Association, Inc. All rights reserved.

7 Retention and engraftment of human cardiac stem cells (hCSCs) and human mesenchymal stem cells (hMSCs) in post–myocardial infarction (MI) swine. Adam R. Williams et al. Circulation. 2013;127:213-223 Copyright © American Heart Association, Inc. All rights reserved.

Download ppt "Enhanced Effect of Combining Human Cardiac Stem Cells and Bone Marrow Mesenchymal Stem Cells to Reduce Infarct Size and to Restore Cardiac Function After."

Similar presentations

prognosis of patients with Acute Myocardial Infarction remains dismal.

prognosis of patients with Acute Myocardial Infarction remains dismal.
Stem Cell Implants to Repair Damaged Hearts Rationale Two clinical trials – Cardiac-derived stem cells Cedars Sinai Medical Center, Dr. Eduardo Marban.

Stem Cell Implants to Repair Damaged Hearts Rationale Two clinical trials – Cardiac-derived stem cells Cedars Sinai Medical Center, Dr. Eduardo Marban.
Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction by Mortimer Korf-Klingebiel,

Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction by Mortimer Korf-Klingebiel,
© 2015 Pearson Education, Inc. Figure 20-17 Pressure and Volume Relationships in the Cardiac Cycle. Aorta Electro- cardiogram (ECG) QRS complex P T ONE.

© 2015 Pearson Education, Inc. Figure Pressure and Volume Relationships in the Cardiac Cycle. Aorta Electro- cardiogram (ECG) QRS complex P T ONE.
Date of download: 6/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Synergistic Effects of Combined Cell Therapy for.

Date of download: 6/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Synergistic Effects of Combined Cell Therapy for.
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Cardiopoietic Stem Cell Therapy in Heart Failure:

Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Cardiopoietic Stem Cell Therapy in Heart Failure:
Date of download: 7/7/2016 Copyright © The American College of Cardiology. All rights reserved. From: Stem Cell Mobilization by Granulocyte Colony-Stimulating.

Date of download: 7/7/2016 Copyright © The American College of Cardiology. All rights reserved. From: Stem Cell Mobilization by Granulocyte Colony-Stimulating.
Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011CLINICAL PERSPECTIVE by Harlan M. Krumholz, Sharon-Lise T.

Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011CLINICAL PERSPECTIVE by Harlan M. Krumholz, Sharon-Lise T.
Cumulative Radiation Exposure and Cancer Risk Estimation in Children With Heart DiseaseCLINICAL PERSPECTIVE by Jason N. Johnson, Christoph P. Hornik, Jennifer.

Cumulative Radiation Exposure and Cancer Risk Estimation in Children With Heart DiseaseCLINICAL PERSPECTIVE by Jason N. Johnson, Christoph P. Hornik, Jennifer.
Elastin Stabilizes an Infarct and Preserves Ventricular Function by Tomohiro Mizuno, Terrence M. Yau, Richard D. Weisel, Chris G. Kiani, and Ren- Ke Li.

Elastin Stabilizes an Infarct and Preserves Ventricular Function by Tomohiro Mizuno, Terrence M. Yau, Richard D. Weisel, Chris G. Kiani, and Ren- Ke Li.
Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction by Mikhail Kosiborod, Saif S. Rathore, Silvio E. Inzucchi,

Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction by Mikhail Kosiborod, Saif S. Rathore, Silvio E. Inzucchi,
Can Adenosine 5′-Triphosphate Be Used to Select Treatment in Severe Vasovagal Syndrome? by Daniel Flammang, Timothy Church, Marc Waynberger, Annick Chassing,

Can Adenosine 5′-Triphosphate Be Used to Select Treatment in Severe Vasovagal Syndrome? by Daniel Flammang, Timothy Church, Marc Waynberger, Annick Chassing,
Preserving Prostaglandin E2 Level Prevents Rejection of Implanted Allogeneic Mesenchymal Stem Cells and Restores Postinfarction Ventricular Function by.

Preserving Prostaglandin E2 Level Prevents Rejection of Implanted Allogeneic Mesenchymal Stem Cells and Restores Postinfarction Ventricular Function by.
Date of download: 9/20/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effect of Aging on Human Mesenchymal Stem Cell Therapy.

Date of download: 9/20/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effect of Aging on Human Mesenchymal Stem Cell Therapy.
Pharmacotherapy Of Cardiovascular Disorders: Heart Failure

Pharmacotherapy Of Cardiovascular Disorders: Heart Failure
Cardiac Physiology Class 1.

Cardiac Physiology Class 1.
Impact of weight reduction on pericardial adipose tissue and cardiac structure in patients with atrial fibrillation  Hany S. Abed, BPharm, MBBS, PhD,

Impact of weight reduction on pericardial adipose tissue and cardiac structure in patients with atrial fibrillation  Hany S. Abed, BPharm, MBBS, PhD,
Fatal and Nonfatal Cardiovascular Disease and the Use of Therapies for Secondary Prevention in a Rural Region of India by Rohina Joshi, Clara K. Chow,

Fatal and Nonfatal Cardiovascular Disease and the Use of Therapies for Secondary Prevention in a Rural Region of India by Rohina Joshi, Clara K. Chow,
Echocardiographic modalities for evaluation and risk stratification of heart failure patients. 3D indicates 3-dimensional; EF, ejection fraction; LA, left.

Echocardiographic modalities for evaluation and risk stratification of heart failure patients. 3D indicates 3-dimensional; EF, ejection fraction; LA, left.
Imatinib Mesylate Attenuates Myocardial Remodeling Through Inhibition of Platelet-Derived Growth Factor and Transforming Growth Factor Activation in a.

Imatinib Mesylate Attenuates Myocardial Remodeling Through Inhibition of Platelet-Derived Growth Factor and Transforming Growth Factor Activation in a.

Similar presentations

Ads by Google